申请人:Nirsum Laboratories, Inc.
公开号:US10544154B2
公开(公告)日:2020-01-28
Provided herein are prodrugs of opioid receptor antagonists such as nalmefene and naltrexone, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of behavioral disorders.
本文提供了阿片受体拮抗剂(如纳美芬和纳曲酮)的原药、包含所述化合物的药物组合物以及使用所述化合物治疗行为紊乱的方法。